annb0t
Top 20
MELBOURNE, Australia, Oct. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) relating to a proposed listing of American Depository Shares (ADS), representing the Company's ordinary shares, on the Nasdaq Stock Market (Nasdaq). (PRNewsfoto/Telix Pharmaceuticals Limited)
The proposed Nasdaq listin...
>>> Read more: Telix Files Form 20-F Registration Statement for Nasdaq ADS
The proposed Nasdaq listin...
>>> Read more: Telix Files Form 20-F Registration Statement for Nasdaq ADS
